1Y Annualised Return
▲3.56%
3Y Annualised Return
▲7.72%
5Y Annualised Return
▲0.44%
Over the past
Open
942.30
Prev. Close
939.60
Total Traded Value
5.36 Cr
Market Cap (in crs)
18,612.56
Face Value
2
Turnover (in lacs)
535.63
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
1769.64 Cr | 1692.74 Cr | 1647.98 Cr | 1561.73 Cr | 1516.98 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
6714.63 Cr | 6256.93 Cr | 5655.36 Cr | 5356.25 Cr | 5403.15 Cr | 4610.69 Cr |
Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
157.29 Cr | 137.34 Cr | 152.28 Cr | 134.22 Cr | 178.6 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
581.14 Cr | 616.8 Cr | 372.91 Cr | 515.65 Cr | 1114.76 Cr | 800.65 Cr |
Alembic Pharmaceuticals Ltd reported a 10.7% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 8.0%.
Its expenses for the quarter were down by 12.3% QoQ and up 4.3% YoY.
The net profit increased 29.4% QoQ and increased 16.8% YoY.
The earnings per share (EPS) of Alembic Pharmaceuticals Ltd stood at 9.1 during Q4FY25.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Period | Combined Delivery Volume | NSE+BSE Traded Volume |
---|---|---|
Day Rs | 21758 Rs | 63847 Rs |
Week Rs | 67393 Rs | 132033 Rs |
Month Rs | 39998 Rs | 94157 Rs |
A
C
J
N
E
O
Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
21,946.25 | 6069.7 | 10691 | 8,876.00 | -12.82% | 10.29% | 36.67% | 38.95% | 220.96% | 0.00% | 125.66 | 41.49 | 28.55 | ||
15,631.05 | 1365 | 2641 | 2,022.50 | -1.13% | -6.22% | -14.21% | 44.73% | 196.74% | 0.27% | 46.05 | 41.49 | 9.19 | ||
17,844.79 | 701.8 | 1309.9 | 1,121.50 | -0.02% | 4.30% | 2.08% | 52.87% | 225.36% | 0.45% | 0.00 | 41.49 | 7.70 | ||
15,715.33 | 6551 | 18100 | 12,308.00 | -2.26% | 9.80% | -11.49% | 82.69% | 1,065.18% | 0.10% | 77.81 | 41.49 | 10.36 | ||
21,847.41 | 987.1 | 1910 | 1,623.30 | -10.27% | 6.63% | 19.51% | 54.21% | 144.19% | 0.46% | 282.73 | 41.49 | 8.70 | ||
22,785.36 | 1209.95 | 2248 | 1,947.50 | -8.25% | 18.05% | 0.00% | 0.00% | 0.00% | 0.00% | 172.30 | 41.49 | 3.85 |
As of 24 Jun, 2025, Alembic Pharmaceuticals share price is ₹946.9. The stock opened at ₹942.3 and had closed at ₹939.6 the previous day. During today’s trading session, Alembic Pharmaceuticals share price moved between ₹935.00 and ₹956.50, with an average price for the day of ₹945.75. Over the last 52 weeks, the stock has recorded a low of ₹725.20 and a high of ₹1,303.90. In terms of performance, Alembic Pharmaceuticals share price has declined by 9.4% over the past six months and has increased by 3.56% over the last year.
Alembic Pharmaceuticals share price is ₹944.3 in NSE and ₹947.05 in BSE as on 24/6/2025.
Alembic Pharmaceuticals share price in the past 1-year return was 4.91. The Alembic Pharmaceuticals share hit a 1-year low of Rs. 725.2 and a 1-year high of Rs. 1303.9.
The market cap of Alembic Pharmaceuticals is Rs. 18612.56 Cr. as of 24/6/2025.
The PE ratios of Alembic Pharmaceuticals is 38.08 as of 24/6/2025.
The PB ratios of Alembic Pharmaceuticals is 3.58 as of 24/6/2025
The Mutual Fund Shareholding in Alembic Pharmaceuticals was 9.2% at the end of 24/6/2025.
You can easily buy Alembic Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Alembic Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.